Bank of America Boosts Stevanato Group (NYSE:STVN) Price Target to $26.00

Stevanato Group (NYSE:STVN) had its price objective hoisted by Bank of America from $24.00 to $26.00 in a report published on Friday,Benzinga reports. They currently have a buy rating on the stock.

STVN has been the subject of several other research reports. Wolfe Research started coverage on shares of Stevanato Group in a report on Friday. They issued an “outperform” rating and a $28.00 target price for the company. Morgan Stanley reaffirmed an “equal weight” rating and issued a $23.00 price objective (down previously from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of €28.60 ($30.11).

Stevanato Group Trading Up 3.7 %

NYSE STVN opened at €23.31 ($24.54) on Friday. Stevanato Group has a 52 week low of €16.56 ($17.43) and a 52 week high of €34.73 ($36.56). The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22. The stock’s 50-day moving average price is €19.67 and its 200-day moving average price is €19.68.

Stevanato Group (NYSE:STVN) last released its earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing analysts’ consensus estimates of €0.13 ($0.14) by (€0.01) (($0.01)). The firm had revenue of €277.90 million for the quarter, compared to the consensus estimate of €274.36 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. Stevanato Group’s revenue was up 2.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.16 EPS. Equities research analysts predict that Stevanato Group will post 0.5 EPS for the current year.

Institutional Trading of Stevanato Group

Hedge funds have recently bought and sold shares of the stock. nVerses Capital LLC purchased a new position in shares of Stevanato Group during the third quarter valued at about $84,000. Raymond James Trust N.A. boosted its stake in Stevanato Group by 18.7% during the second quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock valued at $188,000 after buying an additional 1,613 shares during the last quarter. Oppenheimer Asset Management Inc. grew its holdings in Stevanato Group by 59.2% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 11,941 shares of the company’s stock valued at $219,000 after buying an additional 4,441 shares in the last quarter. Hardy Reed LLC increased its stake in Stevanato Group by 8.2% in the 3rd quarter. Hardy Reed LLC now owns 11,077 shares of the company’s stock worth $222,000 after acquiring an additional 840 shares during the last quarter. Finally, Lindenwold Advisors INC boosted its position in shares of Stevanato Group by 13.5% during the 3rd quarter. Lindenwold Advisors INC now owns 11,930 shares of the company’s stock valued at $239,000 after acquiring an additional 1,415 shares during the last quarter.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.